Misonix Inc (MSON) Stock Price, Quote, News and Overview
NASDAQ:MSON - Nasdaq -
MSON Quote, Performance and Key Statistics
26.54
+1.2 (+4.74%)
The current stock price of MSON is 26.54 null. In the past month the price increased by 4.9%. In the past year, price increased by 133.63%.
MSON Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
| ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
| SYK | STRYKER CORP | 31.4 | 145.92B | ||
| MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
| BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
| IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
| DXCM | DEXCOM INC | 53.81 | 34.68B | ||
| RMD | RESMED INC | 26.21 | 34.03B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Related stock screener links
About MSON
Company Profile
Misonix, Inc. is a medical device company, which engages in the design, development, manufacture and marketing of therapeutic ultrasonic medical devices. The company is headquartered in Farmingdale, New York and currently employs 281 full-time employees. The firm is engaged in designing, manufacturing and marketing of minimally invasive therapeutic ultrasonic medical devices. Its products include BoneScalpel Surgical System (BoneScalpel), SonicOne Wound Cleansing and Debridement System (SonicOne) and SonaStar Surgical Aspirator (SonaStar). BoneScalpel is used for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue. SonaStar is used to emulsify and remove soft and hard tumors, primarily in the neuro and general surgery field. SonicOne offers tissue specific debridement and cleansing of wounds and burns for effective removal of devitalized tissue and fibrin deposits while sparing viable cells. The Company’s products are nexus, BoneScalpel, SonaStar, SonicOne, TheraSkin and Therion.
Company Info
Misonix Inc
1938 New Hwy
Farmingdale NEW YORK 11735 US
CEO: Stavros G. Vizirgianakis
Employees: 281
Company Website: https://misonix.com/
Phone: 16319279113.0
Misonix Inc / MSON FAQ
What is the stock price of Misonix Inc today?
The current stock price of MSON is 26.54 null. The price increased by 4.74% in the last trading session.
What is the ticker symbol for Misonix Inc stock?
The exchange symbol of Misonix Inc is MSON and it is listed on the Nasdaq exchange.
On which exchange is MSON stock listed?
MSON stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for Misonix Inc stock?
3 analysts have analysed MSON and the average price target is 28.56 null. This implies a price increase of 7.61% is expected in the next year compared to the current price of 26.54. Check the Misonix Inc stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is Misonix Inc worth?
Misonix Inc (MSON) has a market capitalization of 462.06M null. This makes MSON a Small Cap stock.
How many employees does Misonix Inc have?
Misonix Inc (MSON) currently has 281 employees.
What are the support and resistance levels for Misonix Inc (MSON) stock?
Misonix Inc (MSON) has a support level at 25.6 and a resistance level at 26.54. Check the full technical report for a detailed analysis of MSON support and resistance levels.
Is Misonix Inc (MSON) expected to grow?
The Revenue of Misonix Inc (MSON) is expected to grow by 16.14% in the next year. Check the estimates tab for more information on the MSON EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy Misonix Inc (MSON) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MSON, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MSON, evaluating the profitability, health, valuation and growth aspects
- Misonix Inc (MSON) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Misonix Inc (MSON) Sales and EPS estimates to see what analysts future expectations are.
- Misonix Inc (MSON) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Misonix Inc (MSON) Insider and Institutional Ownership to learn about the owners and their transactions.
- Misonix Inc (MSON) Stock Chart to make your own analysis
- Misonix Inc (MSON) Latest news and press-releases to stay up to date.
Does Misonix Inc (MSON) stock pay dividends?
MSON does not pay a dividend.
When does Misonix Inc (MSON) report earnings?
Misonix Inc (MSON) will report earnings on 2022-02-11, after the market close.
What is the Price/Earnings (PE) ratio of Misonix Inc (MSON)?
Misonix Inc (MSON) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.84).
MSON Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to MSON. When comparing the yearly performance of all stocks, MSON is one of the better performing stocks in the market, outperforming 90.14% of all stocks.
MSON Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to MSON. MSON scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
MSON Financial Highlights
Over the last trailing twelve months MSON reported a non-GAAP Earnings per Share(EPS) of -0.84. The EPS increased by 16% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -19.55% | ||
| ROA | -7.28% | ||
| ROE | N/A | ||
| Debt/Equity | 0.29 |
MSON Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 60% to MSON. The Buy consensus is the average rating of analysts ratings from 3 analysts.
For the next year, analysts expect an EPS growth of 10.14% and a revenue growth 16.14% for MSON